Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,429 | 82,398 | 39,038 | 71,902 | 31,667 |
| Marketable Securities | 441 | 1,106 | 97,366 | N/A | N/A |
| Receivables | 3,926 | 2,985 | 2,618 | 732 | 394 |
| TOTAL | $29,700 | $89,654 | $141,018 | $73,915 | $32,632 |
| Non-Current Assets | |||||
| PPE Net | 19,345 | 12,707 | 7,246 | 2,277 | 2,440 |
| Investments And Advances | 32,999 | 189,002 | 170,127 | 10,000 | 0 |
| Intangibles | 109,311 | 106,314 | 24,538 | 28,398 | 57,362 |
| Other Non-Current Assets | 240,258 | 3,909 | 590 | 26,951 | 148 |
| TOTAL | $401,913 | $311,932 | $202,501 | $67,626 | $59,950 |
| Total Assets | $431,613 | $401,586 | $343,519 | $141,541 | $92,582 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 209 | 4,835 | 3,316 | 374 |
| Accounts payable and accrued liabilities | 63,120 | 56,644 | 13,339 | 1,656 | 2,153 |
| Accrued Expenses | 11,759 | 8,306 | 6,288 | 2,692 | 2,049 |
| Other current liabilities | 212 | 248 | 5,520 | N/A | N/A |
| TOTAL | $78,955 | $76,085 | $30,873 | $9,557 | $5,480 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,211 | 47,107 | 4,394 | 8,830 | 4,431 |
| Deferred Revenues | 3,864 | 10,678 | 891 | 1,893 | 904 |
| Other Non-Current Liabilities | 4,038 | 7,292 | 11,324 | 10,912 | 117 |
| TOTAL | $146,048 | $238,999 | $171,708 | $23,271 | $20,293 |
| Total Liabilities | $225,003 | $315,084 | $202,581 | $32,828 | $25,773 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,434 | 50,887 | 38,366 | 36,206 | 23,028 |
| Common Shares | 9 | 6 | 4 | 4 | 2 |
| Retained earnings | -165,120 | -174,252 | -113,329 | -67,518 | -32,861 |
| Other shareholders' equity | 6,820 | 5,883 | 69,365 | 0 | 0 |
| TOTAL | $206,610 | $86,502 | $140,938 | $108,713 | $66,809 |
| Total Liabilities And Equity | $431,613 | $401,586 | $343,519 | $141,541 | $92,582 |